trending Market Intelligence /marketintelligence/en/news-insights/trending/jlkN1o8RJ9dyN5LWxSYYsw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Amgen CFO David Meline to retire; replacement named

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Amgen CFO David Meline to retire; replacement named

Amgen Inc. said David Meline is retiring as CFO and executive vice president of the company.

Meline, who has served in those positions since 2014, will continue to serve as CFO of through the end of 2019 and will remain with Amgen until the second quarter of 2020 to aid with the transition.

Meanwhile, Peter Griffith was appointed executive vice president of finance and will replace Meline as Amgen's CFO on Jan. 1, 2020.

Griffith was previously president of private equity firm Sherwood Canyon Group LLC. He also previously served as global vice chair for corporate development at advisory service firm EY.

Thousand Oaks, Calif.-based Amgen develops therapies in the fields of oncology, hematology, cardiovascular, inflammation, bone health and neuroscience.